News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Spruce Biosciences (SPRB) Gains FDA Support for Accelerated Approval Pathway [Yahoo! Finance]

Spruce Biosciences to Present at Upcoming Investor Conferences in March [Yahoo! Finance]

Spruce Biosciences to Present at Upcoming Investor Conferences in March

Spruce Biosciences (NASDAQ:SPRB) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)

Oppenheimer Holdings, Inc.

Form SCHEDULE 13G SPRUCE BIOSCIENCES, INC. Filed by: INTEGRATED CORE STRATEGIES (US) LLC

Form SCHEDULE 13D/A SPRUCE BIOSCIENCES, INC. Filed by: Carlyle Group Inc.

Form SCHEDULE 13G SPRUCE BIOSCIENCES, INC. Filed by: ADAR1 Capital Management, LLC

Form SCHEDULE 13G SPRUCE BIOSCIENCES, INC. Filed by: Alyeska Investment Group, L.P.

Form SCHEDULE 13G/A SPRUCE BIOSCIENCES, INC. Filed by: CITADEL ADVISORS LLC

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}